脑膜瘤治疗模式的发展;精准医学的前景
Daniela Galluzzo1,2, Casandra Chen1,2, Khaled Alok1,3
1Chenevert Brain Tumor Center, Smilow Cancer Center, Yale University School of Medicine, New Haven, USA.
Current neurology and neuroscience reports
|October 14, 2025
概括
本综述涵盖了内膜瘤的多学科管理,强调了新的向治疗方法. 进展包括精细化手术,放射治疗和复杂病例的新兴全身治疗.
科学领域:
- 神经瘤学神经瘤学
- 神经外科 神经外科
- 辐射瘤学 辐射瘤学
- 医学瘤学 医学瘤学
背景情况:
- 内膜瘤是不同的瘤,需要多学科的护理.
- 2021年世界卫生组织分类引入了分级分子标记.
- 晚期或复发性脑膜瘤的管理仍然具有挑战性.
研究的目的:
- 提供当前内膜瘤管理的全面概述.
- 专注于新和新兴的治疗策略.
- 解决治疗高度和复发性脑膜瘤的挑战.
主要方法:
- 审查关于脑膜瘤管理的当前文献.
- 分析手术技术和放射治疗方面的进步.
- 探索新兴的全身疗法,包括向治疗和免疫疗法.
主要成果:
- 最大安全的手术切除是主要的治疗方式.
- 分子变化对于脑膜瘤分级和管理越来越重要.
- 精细的手术和放射治疗策略改善了结果.
- 针对性疗法和免疫疗法对晚期/复发性脑膜瘤具有前景.
结论:
- 多学科管理对于优化内脑膜瘤治疗至关重要.
- 新兴的向疗法和免疫疗法代表着未来有希望的方向.
- 需要进一步的研究来解决异质性,并改善复杂案件的选择.
相关概念视频
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


